Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1959 4
1960 1
1962 2
1963 1
1965 2
1966 3
1967 3
1968 6
1969 6
1970 7
1971 9
1972 6
1973 4
1974 18
1975 9
1976 11
1977 9
1978 11
1979 9
1980 10
1981 16
1982 11
1983 18
1984 28
1985 26
1986 19
1987 11
1988 9
1989 18
1990 18
1991 4
1992 5
1993 6
1994 6
1995 3
1996 2
1997 9
1998 4
1999 3
2000 2
2001 6
2002 4
2003 6
2004 7
2005 6
2006 8
2007 3
2008 7
2009 11
2010 6
2011 6
2012 6
2013 4
2014 7
2015 10
2016 7
2017 7
2018 8
2019 7
2020 6
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

475 results
Results by year
Filters applied: . Clear all
Page 1
RNA-Seq of single prostate CTCs implicates noncanonical Wnt signaling in antiandrogen resistance.
Miyamoto DT, Zheng Y, Wittner BS, Lee RJ, Zhu H, Broderick KT, Desai R, Fox DB, Brannigan BW, Trautwein J, Arora KS, Desai N, Dahl DM, Sequist LV, Smith MR, Kapur R, Wu CL, Shioda T, Ramaswamy S, Ting DT, Toner M, Maheswaran S, Haber DA. Miyamoto DT, et al. Among authors: dahl dm. Science. 2015 Sep 18;349(6254):1351-6. doi: 10.1126/science.aab0917. Science. 2015. PMID: 26383955 Free PMC article.
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Giacalone NJ, Shipley WU, Clayman RH, Niemierko A, Drumm M, Heney NM, Michaelson MD, Lee RJ, Saylor PJ, Wszolek MF, Feldman AS, Dahl DM, Zietman AL, Efstathiou JA. Giacalone NJ, et al. Among authors: dahl dm. Eur Urol. 2017 Jun;71(6):952-960. doi: 10.1016/j.eururo.2016.12.020. Epub 2017 Jan 9. Eur Urol. 2017. PMID: 28081860
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer.
Miyamoto DT, Lee RJ, Kalinich M, LiCausi JA, Zheng Y, Chen T, Milner JD, Emmons E, Ho U, Broderick K, Silva E, Javaid S, Kwan TT, Hong X, Dahl DM, McGovern FJ, Efstathiou JA, Smith MR, Sequist LV, Kapur R, Wu CL, Stott SL, Ting DT, Giobbie-Hurder A, Toner M, Maheswaran S, Haber DA. Miyamoto DT, et al. Among authors: dahl dm. Cancer Discov. 2018 Mar;8(3):288-303. doi: 10.1158/2159-8290.CD-16-1406. Epub 2018 Jan 4. Cancer Discov. 2018. PMID: 29301747 Free PMC article. Clinical Trial.
Commentary.
Dahl DM. Dahl DM. J Am Coll Surg. 2009 Sep;209(3):376-7. doi: 10.1016/j.jamcollsurg.2009.06.366. J Am Coll Surg. 2009. PMID: 19717043 No abstract available.
Reply by Authors.
Salari K, Kuppermann D, Preston MA, Dahl DM, Barrisford GW, Efstathiou JA, Blute ML, Vesprini D, Loblaw A, Zietman AL, Klotz L, Feldman AS. Salari K, et al. Among authors: dahl dm. J Urol. 2019 Oct;202(4):821-822. doi: 10.1097/JU.0000000000000363. Epub 2019 Sep 6. J Urol. 2019. PMID: 31163004 No abstract available.
Introduction of biosimilar insulins in Europe.
Davies M, Dahl D, Heise T, Kiljanski J, Mathieu C. Davies M, et al. Among authors: dahl d. Diabet Med. 2017 Oct;34(10):1340-1353. doi: 10.1111/dme.13400. Epub 2017 Jul 16. Diabet Med. 2017. PMID: 28608570 Free PMC article. Review.
Editorial comment.
Dahl DM. Dahl DM. Urology. 2011 Jan;77(1):136. doi: 10.1016/j.urology.2010.04.061. Urology. 2011. PMID: 21195833 No abstract available.
475 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page